drugset / Trial / NCT00517621

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

NCT00517621 ↗

Phase 2 Completed 100 enrolled ARCAGY/ GINECO GROUP
Non-randomizedSingle-groupOpen-labelTreatment

Summary

validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.

Timeline

Start
2006-02
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject EPO Unknown — —
Subject Paclitaxel Small molecule — —